Coronary Artery Disease (CAD) is the most common heart disease with a high morbidity and mortality rate. Dual antiplatelet therapy (DAPT) is integral to CAD management, and involves administering an anticoagulant such as aspirin along with P2Y12 receptor inhibitor. The optimal duration of DAPT can vary depending on the severity of complications, stent type, and patient medical history. The role of interventional cardiologists is, therefore, crucial in the management of CAD as several complex parameters are involved. In this regard, Docplexus has organized an interactive webinar on “Insights into the Future of CAD Management” by cardiology experts Dr.
Ralph Brindis, Dr. Keyur Parikh , and Dr. Tejas V Patel on 25th April 2021 , 6:00 PM onwards . In this session, the experts will share their insights on the topics, “Choosing Wisely - How Clinicians can Prepare for their Future?” and…
